Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.84 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bluejay Diagnostics (BJDX) Return on Sales [ROS] (2022)

Updated

Bluejay Diagnostics' Return on Sales [ROS] was -3741.48% in FY2022.

Analysis

Bluejay Diagnostics (BJDX) Return on Sales [ROS] (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Bluejay Diagnostics 1.67 Mn 1.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -797.35%
API Access

Bluejay Diagnostics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BJDX&period=max&api_key=YOUR_API_KEY